NS
CPRX

NBC Securities’s Catalyst Pharmaceutical CPRX Stock Holding History

NBC Securities’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.82K Hold
235
– – ﹤0.01% 2076
2025
Q4 		$5.48K Buy
+235
New +$5.24K ﹤0.01% 2183
2025
Q2 		– Sell
-578
Closed -$14K – 2459
2025
Q1 		$14K Buy
+578
New +$13K ﹤0.01% 1617

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

NBC Securities's CPRX Position: Q1 2026 in Review

NBC Securities held its Catalyst Pharmaceutical (CPRX) position steady in Q1 2026 at 235 shares worth $5.82K. The position accounts for ﹤0.01% of the portfolio, ranked #2076.

NBC Securities first reported a position in CPRX in Q1 2025 and has held it in 3 quarters since. The position peaked at $14K in Q1 2025. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • NBC Securities held 235 shares of Catalyst Pharmaceutical worth $5.82K as of Q1 2026.
  • NBC Securities left its Catalyst Pharmaceutical share count unchanged in Q1 2026.
  • Catalyst Pharmaceutical made up ﹤0.01% of NBC Securities's portfolio in Q1 2026, its #2076 holding.
  • NBC Securities first reported a position in Catalyst Pharmaceutical in Q1 2025 and has held it in 3 quarters since.
  • NBC Securities's Catalyst Pharmaceutical position peaked at $14K in Q1 2025.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on NBC Securities's 13F filing for Q1 2026, filed 14 Apr 2026.